Autori: Bila Jelena S
| Naslov | Lighthouse: melflufen, daratumumab, and dexamethasone versus daratumumab in relapsed/refractory multiple myeloma refractory to an imid and a proteasome inhibitor or with ≥3 prior lines of therapy (Meeting Abstract) |
| Autori | Mateos Maria-Victoria Szarejko Monika Bila Jelena S Schjesvold Fredrik Spicka Ivan Maisnar Vladimir Jurczyszyn Artur Grudeva-Popova Zhanet Hajek Roman Usenko Hanna Thuresson Marcus Norin Stefan Jarefors Sara Richardson Paul Pour Ludek |
| Info | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, (2023), vol. 23 br. , Suppl. 2, str. S200-S201 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa |
| Naslov | The second revision of international staging system (R2-ISS) in newly diagnosed multiple myeloma patients: RWE settings (Meeting Abstract) |
| Autori | Sretenovic Aleksandra M Mitrovic Marko Vukosavljevic Nikola Kecman Natalija Jovanovic Jelica V Bukumiric Zoran M Bila Jelena S |
| Info | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, (2023), vol. 23 br. , Suppl. 2, str. S93-S93 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa |
| Naslov | MajesTEC-4: Phase 3 trial of Teclistamab plus Lenalidomide versus Lenalidomide in patients with newly diagnosed multiple myeloma (Meeting Abstract) |
| Autori | Cook Gordon ... Bila Jelena S ... (broj koautora 22) |
| Info | BRITISH JOURNAL OF HAEMATOLOGY, (2023), vol. 201 br. , Suppl. 1, str. 57-57 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa |
| Naslov | Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network (Review) |
| Autori | Ludwig Heinz ... Bila Jelena S ... (broj koautora 29) |
| Info | LANCET ONCOLOGY, (2023), vol. 24 br. 6, str. E255-E269 |
| Projekat | Austrian Forum Against Cancer |
| Ispravka | ISI/Web of Science Elečas Rang časopisa |
| Naslov | MajesTEC-4 (EMN30): A Phase 3 Trial of Teclistamab plus Lenalidomide Versus Lenalidomide Alone As Maintenance Therapy Following Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma (Meeting Abstract) |
| Autori | Zamagni Elena ... Bila Jelena S ... (broj koautora 22) |
| Info | BLOOD, (2022), vol. 140 br. , Suppl. 1, str. 7289-7291 |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
| Naslov | Subcutaneous Daratumumab Plus Pomalidomide and Dexamethasone (D-Pd) Versus Pomalidomide and Dexamethasone (Pd) Alone in Patients with Relapsed or Refractory Multiple Myeloma (RRMM): Overall Survival Results from the Phase 3 Apollo Study (Meeting Abstract) |
| Autori | Dimopoulos Meletios Athanasios Terpos Evangelos Boccadoro Mario Delimpasi Sosana Beksac Meral Katodritou Eirini Moreau Philippe Baldini Luca Symeonidis Argiris Bila Jelena S Oriol Albert Mateos Maria-Victoria Einsele Hermann Orfanidis Ioannis Kampfenkel Tobias Liu Weiping Kosh Michele NamPhuong Tran Carson Robin Sonneveld Pieter |
| Info | BLOOD, (2022), vol. 140 br. , Suppl. 1, str. 7272-7274 |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
| Naslov | Ocrelizumab associated late-onset neutropenia in the patient with multiple sclerosis - case report and literature review (Review) |
| Autori | Jovicevic Vanja Bila Jelena S Mesaros Sarlota T Pekmezovic Tatjana D Drulovic Jelena S |
| Info | SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, (2022), vol. 150 br. 5-6, str. 354-356 |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Health-related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone +/- subcutaneous daratumumab: Patient-reported outcomes from the APOLLO trial (Article) |
| Autori | Terpos Evangelos ... Bila Jelena S ... (broj koautora 23) |
| Info | AMERICAN JOURNAL OF HEMATOLOGY, (2022), vol. 97 br. 4, str. 481-490 |
| Projekat | European Myeloma Network (EMN); Janssen Research & Development, LLC; Janssen Global Services, LLC |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | APOLLO: Phase 3 randomized study of subcutaneous Daratumumab plus Pomalidomide and Dexamethasone (D-Pd) versus Pomalidomide and Dexamethasone (Pd) alone in patients with Relapsed/Refractory Multiple Myeloma (RRMM) (Meeting Abstract) |
| Autori | Einsele H ... Bila Jelena S ... (broj koautora 23) |
| Info | ONCOLOGY RESEARCH AND TREATMENT, (2021), vol. 44 br. , Suppl. 2, str. 178-178 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Clinical Outcomes in Patients (Pts) with Dose Reduction of Selinexor in Combination with Bortezomib, and Dexamethasone (XVd) in Previously Treated Multiple Myeloma from the Boston Study (Meeting Abstract) |
| Autori | Jagannath Sundar ... Bila Jelena S ... (broj koautora 45) |
| Info | BLOOD, (2021), vol. 138 br. , Suppl. 1, str. 3793-+ |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
